Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bangkok Dusit Medical Services PCLBDULF 68 Peter Lynch Fair Value is $0.31 as of Jul. 26, 2026, which is 92% below its 10-year median of 3.98. GuruFocus rates BDULF with a GF Score™ of 68/100 and a GF Value™ of $0.97 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 170 Healthcare Providers & Services companies, Bangkok Dusit Medical Services PCL ranks worse than 68.24% on this metric.
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
The historical rank and industry rank for Bangkok Dusit Medical Services PCL's Peter Lynch Fair Value or its related term are showing as below:
BDULF'
s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 1.63 Med: 3.98 Max: 6.42
Current: 1.75
During the past 13 years, the highest Price to Peter Lynch Fair Value Ratio of Bangkok Dusit Medical Services PCL was 6.42. The lowest was 1.63. And the median was 3.98.
BDULF's Price-to-Peter-Lynch-Fair-Value is ranked worse than 68.24% of 170
companies
in the Healthcare Providers & Services industry
Industry Median: 1.2
vs BDULF: 1.75
Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.
Bangkok Dusit Medical Services PCL (OTCPK:BDULF) Peter Lynch Fair Value Explanation
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.
Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.
Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 10.43 instead of 15 in this case.
Bangkok Dusit Medical Services PCL's Price to Peter Lynch Fair Value Ratio for today is calculated as
Price to Peter Lynch Fair Value
=
Share Price
/
Peter Lynch Fair Value
=
0.5596
/
0.31
=
1.79
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bangkok Dusit Medical Services PCL Peter Lynch Fair Value Related Terms
Bangkok Dusit Medical Services PCL Peter Lynch Fair Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bangkok Dusit Medical Services PCL Peter Lynch Fair Value Chart
BDULF vs HCA, THC, DVA: Peter Lynch Fair Value Comparison
For the Medical Care Facilities subindustry, Bangkok Dusit Medical Services PCL's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bangkok Dusit Medical Services PCL Price-to-Peter-Lynch-Fair-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bangkok Dusit Medical Services PCL's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:
* The bar in red indicates where Bangkok Dusit Medical Services PCL's Price-to-Peter-Lynch-Fair-Value falls into.
Bangkok Dusit Medical Services PCL's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.03.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.
If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.
If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.
Bangkok Dusit Medical Services PCL (BDULF) has a Peter Lynch Fair Value of $0.31 as of Jul. 26, 2026. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Bangkok Dusit Medical Services PCL and its competitors. This is 92% below median its historical median of 3.98. Over the past decade, Bangkok Dusit Medical Services PCL's Peter Lynch Fair Value has ranged from 1.63 to 6.42. According to the industry distribution chart, Bangkok Dusit Medical Services PCL ranks #116 out of 170 companies in the Healthcare Providers & Services industry, placing it in the top 68.2%.
Is Bangkok Dusit Medical Services PCL's Peter Lynch Fair Value too high?
Bangkok Dusit Medical Services PCL's current Peter Lynch Fair Value of $0.31 is 92% below median its 10-year median of 3.98. Over the past 10 years, this metric has ranged from a low of 1.63 to a high of 6.42. The Healthcare Providers & Services industry median Peter Lynch Fair Value is 1.20. Bangkok Dusit Medical Services PCL's value of $0.31 is 74.2% below this industry median. Based on the distribution chart, Bangkok Dusit Medical Services PCL ranks #116 out of 170 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Bangkok Dusit Medical Services PCL has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bangkok Dusit Medical Services PCL's Peter Lynch Fair Value compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Bangkok Dusit Medical Services PCL ranks #116 out of 170 companies for Peter Lynch Fair Value. This places Bangkok Dusit Medical Services PCL in the lower half of its industry. The industry median Peter Lynch Fair Value is 1.20. Bangkok Dusit Medical Services PCL's value of $0.31 is 74.2% below this benchmark. Historically, Bangkok Dusit Medical Services PCL's own Peter Lynch Fair Value has ranged from 1.63 to 6.42 over the past decade. While the company's 10-year median is 3.98 vs. the industry median of 1.20, Bangkok Dusit Medical Services PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Peter Lynch Fair Value for a Healthcare Providers & Services company?
The median Peter Lynch Fair Value among Healthcare Providers & Services companies is 1.20, based on 170 companies in the industry. Companies in the top quartile (top 25%) have a Peter Lynch Fair Value significantly above this median, while those in the bottom quartile fall well below. However, Peter Lynch Fair Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bangkok Dusit Medical Services PCL's current Peter Lynch Fair Value of $0.31 is 74.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Peter Lynch Fair Value mean?
A high Peter Lynch Fair Value can signal that a stock is expensive relative to its fundamentals. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Bangkok Dusit Medical Services PCL and its competitors. For the Healthcare Providers & Services industry, the median Peter Lynch Fair Value is 1.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bangkok Dusit Medical Services PCL's current Peter Lynch Fair Value is $0.31, which is 92% below median its own 10-year median of 3.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Dusit Medical Services PCL stock overvalued right now?
Based on GuruFocus' analysis, Bangkok Dusit Medical Services PCL (BDULF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.97, compared to a current price of $0.56 — trading 42.3% below its estimated fair value. The current Peter Lynch Fair Value is $0.31, which is 92% below median its 10-year median of 3.98 and 74.2% below the Healthcare Providers & Services industry median of 1.20. Bangkok Dusit Medical Services PCL's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Peter Lynch Fair Value calculated?
Peter Lynch Fair Value is calculated from a company's financial statements. For Bangkok Dusit Medical Services PCL (BDULF), the current Peter Lynch Fair Value is $0.31 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bangkok Dusit Medical Services PCL (BDULF) Overvalued in 2026?
Based on GuruFocus' analysis, Bangkok Dusit Medical Services PCL stock appears to be undervalued.
The current stock price of $0.56 is trading 42.3% below its estimated GF Value™ of $0.97.
GuruFocus considers Bangkok Dusit Medical Services PCL to be Significantly Undervalued.
Key valuation signals for BDULF:
Peter Lynch Fair Value: $0.31 (92% below median its 10-year median of 3.98)
GF Value™: $0.97 vs. price of $0.56 (42.3% below fair value)
Industry Position: 74.2% below the Healthcare Providers & Services median (#116 of 170)
No single metric tells the full story. See the BDULF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bangkok Dusit Medical Services PCL Business Description
Bangkok Dusit Medical Services PCL operates a network of private hospitals in Thailand and some overseas markets, under the Bangkok Hospital, Phyathai Hospital, Samitivej Hospital, Paolo Hospital, BNH Hospital, and Royal International Hospital brands. The company has two business segments, namely hospital operations and other businesses that support hospital business, such as medical laboratories, production and distribution of pharmaceutical products/medical equipment/saline, pharmacies, asset management for healthcare business, accounting services, technology and information services, training business, and insurance broker. The company's hospital operations generate the vast majority of its revenue.
68GF Score
Get the complete analysis for BDULF
Peter Lynch Fair Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDULF has been successfully added to your 
